Results of video-assisted thoracic surgery versus thoracotomy in surgical resection of pN2 non-small cell lung cancer in a Chinese high-volume Center

被引:7
作者
Liu, Chengwu [1 ,2 ]
Guo, Chenglin [1 ,2 ]
Gan, Fanyi [1 ,2 ]
Mei, Jiandong [1 ,2 ]
Pu, Qiang [1 ,2 ]
Liu, Zheng [1 ,2 ]
Zhu, Yunke [1 ,2 ]
Liao, Hu [1 ,2 ]
Ma, Lin [1 ,2 ]
Lin, Feng [1 ,2 ]
Liu, Lunxu [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Thorac Surg, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, Western China Collaborat Innovat Ctr Early Diag &, Chengdu 610041, Peoples R China
来源
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES | 2021年 / 35卷 / 05期
关键词
Video-assisted thoracic surgery; Thoracotomy; Non-small cell lung cancer; Mediastinal lymph node; Metastasis; PROPENSITY-MATCHED ANALYSIS; LYMPH-NODE DISSECTION; OPEN LOBECTOMY; THORACOSCOPIC LOBECTOMY; CLINICAL N0; EUROPEAN-SOCIETY; N2; MANAGEMENT; CHEMOTHERAPY; METAANALYSIS;
D O I
10.1007/s00464-020-07624-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose To investigate the short-term outcomes and long-term oncological efficacy of video-assisted thoracic surgery (VATS) for surgical treatment of pN2 non-small cell lung cancer (NSCLC) compared with open thoracotomy (OT). Patients and methods We retrospectively collected data from 1034 patients who underwent pulmonary resection and systemic lymph node dissection for pathological N2 NSCLC from September 2005 to December 2017 (536 patients in VATS group and 498 patients in OT group). Propensity score matching was applied to reduce the confounding effects. Factors affecting survival were assessed by Kaplan-Meier estimates and Cox regression analysis. Results The VATS procedure was associated with shorter operative time compared with the OT procedure (147.96 +/- 58.91 min vs. 165.34 +/- 58.91 min, P < 0.001). No significant difference was identified between the two groups in the number of dissected mediastinal lymph nodes (MLNs) and number of dissected MLNs stations. More patients after VATS procedure received postoperative adjuvant therapy (83.4% vs. 75.5%, P = 0.002). At a median follow-up of 36 (range 4-150) months, comparing VATS procedure and OT procedure, no significant differences were noted in 5-year DFS (20.7% vs. 22.5%, P = 0.89) and 5-year OS (30.7% vs. 34.5%, P = 0.821). The VATS procedure was not found to be an independent predictor of DFS (hazard ratio, 0.986; 95% CI, 0.809 to 1.202) or OS (hazard ratio, 0.977; 95% CI 0.802 to 1.191). Conclusion In this large propensity-matched comparison, the VATS procedure offered comparable short-term outcomes and long-term oncological efficacy for patients with pN2 NSCLC when compared with OT procedure.
引用
收藏
页码:2186 / 2197
页数:12
相关论文
共 41 条
[1]   The International Association for the Study of Lung Cancer Lung Cancer Staging Project Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer [J].
Asamura, Hisao ;
Chansky, Kari ;
Crowley, John ;
Goldstraw, Peter ;
Rusch, Valerie W. ;
Vansteenkiste, Johan F. ;
Watanabe, Hirokazu ;
Wu, Yi-Long ;
Zielinski, Marcin ;
Ball, David ;
Rami-Porta, Ramon .
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (12) :1675-1684
[2]   Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial [J].
Bendixen, Morten ;
Jorgensen, Ole Dan ;
Kronborg, Christian ;
Andersen, Claus ;
Licht, Peter Bjorn .
LANCET ONCOLOGY, 2016, 17 (06) :836-844
[3]   Minimally Invasive Lung Cancer Surgery Performed by Thoracic Surgeons as Effective as Thoracotomy [J].
Boffa, Daniel J. ;
Kosinski, Andrzej S. ;
Furnary, Anthony P. ;
Kim, Sunghee ;
Onaitis, Mark W. ;
Tong, Betty C. ;
Cowper, Patricia A. ;
Hoag, Jessica R. ;
Jacobs, Jeffrey P. ;
Wright, Cameron D. ;
Putnam, Joe B., Jr. ;
Fernandez, Felix G. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (23) :2378-+
[4]   Now or Later: Evaluating the Importance of Chemotherapy Timing in Resectable Stage III (N2) Lung Cancer in the National Cancer Database [J].
Boffa, Daniel J. ;
Hancock, Jacquelyn G. ;
Yao, Xiaopan ;
Goldberg, Sarah ;
Rosen, Joshua E. ;
Kim, Anthony W. ;
Moreno, Amy ;
Detterbeck, Frank C. .
ANNALS OF THORACIC SURGERY, 2015, 99 (01) :200-209
[5]   Lymph Node Evaluation by Open or Video-Assisted Approaches in 11,500 Anatomic Lung Cancer Resections [J].
Boffa, Daniel J. ;
Kosinski, Andrzej S. ;
Paul, Subroto ;
Mitchell, John D. ;
Onaitis, Mark .
ANNALS OF THORACIC SURGERY, 2012, 94 (02) :347-353
[6]   Video-assisted thoracic surgery versus open thoracotomy for non-small-cell lung cancer: a propensity score analysis based on a multi-institutional registry [J].
Cao, Christopher ;
Zhu, Zhi-Hua ;
Yan, Tristan D. ;
Wang, Qun ;
Jiang, Gening ;
Liu, Lunxu ;
Liu, Deruo ;
Wang, Zheng ;
Shao, Wenlong ;
Black, Deborah ;
Zhao, Qian ;
He, Jianxing .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2013, 44 (05) :849-854
[7]   The treatment of patients with stage IIIA non-small cell lung cancer from N2 disease: Who returns to the surgical arena and who survives [J].
Cerfolio, Robert J. ;
Maniscalco, Lee ;
Bryant, Ayesha S. .
ANNALS OF THORACIC SURGERY, 2008, 86 (03) :912-920
[8]   Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival [J].
Decaluwe, Herbert ;
De Leyn, Paul ;
Vansteenkiste, Johan ;
Dooms, Christophe ;
Van Raemdonck, Dirk ;
Nafteux, Philippe ;
Coosemans, Willy ;
Lerut, Toni .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2009, 36 (03) :433-439
[9]   Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer [J].
Depierre, A ;
Milleron, B ;
Moro-Sibilot, D ;
Chevret, S ;
Quoix, E ;
Lebeau, B ;
Braun, D ;
Breton, JL ;
Lemarié, E ;
Gouva, S ;
Paillot, N ;
Bréchot, JM ;
Janicot, H ;
Lebas, FX ;
Terrioux, P ;
Clavier, J ;
Foucher, P ;
Monchâtre, M ;
Coëtmeur, D ;
Level, MC ;
Leclerc, P ;
Blanchon, F ;
Rodier, JM ;
Thiberville, L ;
Villeneuve, A ;
Westeel, V ;
Chastang, C .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :247-253
[10]   What to do with "Surprise" N2? Intraoperative management of patients with non-small cell lung cancer [J].
Detterbeck, Frank .
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (03) :289-302